Acute lymphoblastic leukemia
1 / 47

Acute Lymphoblastic Leukemia - PowerPoint PPT Presentation

  • Updated On :

Acute Lymphoblastic Leukemia. I2 黃 柏 瑋. Malignancy remains the major cause of death to disease between the age of 1 and 15 years The precise cause of childhood cancer is unknow Leukemia , Neuroblastoma , Wilms tumor , retinoblastoma and tumor of liver. Introduction.

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about 'Acute Lymphoblastic Leukemia' - RoyLauris

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

Slide2 l.jpg

Introduction l.jpg
Introduction between the age of

  • Leukemia– the most common malignancy in childhood.

  • Acute leukemia– 97%

    Acute lymphoblastic leukemia– 75%

    Acute myeloblastic leukemia– 20%

  • Chronic leukemia– 3%

    Chronic myelogenous leukemia (Ph positive)

    Juvenile myelomonocytic leukemia ( JMML)

Introduction to pediatric neoplastic disease and tumor l.jpg
Introduction to pediatric neoplastic disease and tumor between the age of

  • Leukemia and a more pronounced rise in central nervous system tumor

  • Boy > girl

Leukemia l.jpg
Leukemia between the age of

  • The most common childhood cancer ( 1/3 of pediatric malignancies ).

  • Acute lymphoblastic leukemia (ALL) represents about 75 % (peak incidence at age 4 years).

  • Acute myeloid leukemia (AML) accounts for about 20 % of leukemia (stable from birth through age 10)

  • Others : CML

Acute lymphoblastic leukemia6 l.jpg
Acute Lymphoblastic Leukemia between the age of

  • Childhood acute lymphoblastic leukemia (also called acute lymphocyticleukemia or ALL).

  • is a disease in which toomanyunderdeveloped infection-fighting white blood cells, called lymphocytes, are found in a child's blood and bonemarrow.

Acute lymphoblastic leukemia7 l.jpg
Acute Lymphoblastic Leukemia between the age of

  • These abnormal cells reproduce very quickly and do not function as healthy white blood cells to help fight infection.

  • the most common form of leukemia

  • the most common kind of childhood cancer.

Acute lymphoblastic leukemia8 l.jpg
Acute Lymphoblastic Leukemia between the age of

  • In the United States, about 3,000 children each year are found to have ALL

  • Peak incidence occurs from 3 to 5 years of age.

Acute lymphoblastic leukemia9 l.jpg
Acute Lymphoblastic Leukemia between the age of

  • the most common symptoms of leukemia:fever, anemia, bleeding and/or bruising ,persistant weakness or tiredness, achiness in the bones or joints, recurrent infections , difficulty breathing (dyspnea) or swollen lymph nodes.

Clinical manifestations l.jpg
Clinical manifestations between the age of

  • Protean

  • Bone marrow failure & Organ infiltration

  • Common symptoms

    Fever ( 60%)

    Malaise ( 50%)

    Pallor ( 40%)

Etiology l.jpg
Etiology between the age of

  • Unknown( usually)

  • Hereditary

    Down’s syndrome

    Leukemia in siblings

  • Chemicals

    Chronic benzene exposure

    Alkylating agents

  • Ionizing radiation

  • Predisposing hematological disease ( MPD, AA)

  • Viruses ( HTLV-1)

Diagnostic criteria l.jpg
Diagnostic criteria between the age of

  • ALL is often difficult to diagnose.

  • The early signs may be similar to the flu or other common diseases.

Diagnostic criteria13 l.jpg
Diagnostic criteria between the age of

  • bone marrow aspiration and biopsy

  • complete blood count (CBC)

  • additional blood tests

  • computerized tomography scan

  • magnetic resonanec imaging (MRI)

  • x-ray

  • ultrasound

  • lymph node biopsy

  • spinal tap/lumbar puncture

Diagnostic criteria14 l.jpg
Diagnostic criteria between the age of

  • Peripheralblood: anemia,thrombocytopenia, variable white cell count with or without blasts.

  • Bonemarrow: hyper-or hypo-cellularity with excess of blasts (blasts>30% of nucleated cells).

Diagnostic criteria15 l.jpg
Diagnostic criteria between the age of

  • Cytochemistry study and surface marker study confirm the lymphoid origin .

Diagnostic criteria16 l.jpg
Diagnostic criteria between the age of

  • blood tests to count the number of each of the different kinds of blood cells..

  • If the results of the blood tests are not normal, a doctor may do a bone marrow biopsy .

  • The chance of recovery (prognosis) depends on how the leukemia cells look under a microscope.

Slide17 l.jpg

V-25 between the age of Leukemic cells in acutelymphoblasticleukemia characterized by round or convoluted nuclei, high nuclear/cytoplasmic ratio and absence of cytoplasmic graulnes.

Differential diagnosis l.jpg
Differential diagnosis between the age of

  • AML.

  • MDS.

  • Non-Hodgkin‘s lymphoma with bone marrow involvement or with leukemic change.

  • CLL.

Differential diagnosis19 l.jpg
Differential diagnosis between the age of

  • Viral infection with lymphocytosis

  • CML with acute blastic crisis.

Acute lymphoblastic leukemia21 l.jpg
Acute lymphoblastic leukemia between the age of

Laboratory examinations l.jpg
Laboratory examinations between the age of

  • Full blood count

  • Coagulation screening – esp AML M3.

  • Biochemical screening

  • Chest radiography

  • Bone marrow aspiration

  • Immunophenotyping

  • Cytogenetics & molecular studies

  • Lumbar puncture ( CNS involvement)

Complications l.jpg
Complications between the age of

  • Cerebral hemorrhage, pul. hemorrhage or other vital organ hemorrhage.

  • Infection(sepsis or septic shock ) , pulmonary edema.

  • Tumor lysis syndrome.

Complications24 l.jpg
Complications between the age of

  • Infiltration syndrome(CNS, GI tract or gonads).

  • Coagulopathy before or after chemotherapy.

  • Anemia.

Risk grouping of tpog all l.jpg
Risk Grouping of TPOG (ALL between the age of )

  • Standard Risk

  • High Risk– CNS leukemia, cranial nerve palsy, testicular leukemia, pre-B ALL t(1;19) or E2A-PBX1 fusion

Very high risk l.jpg
Very High Risk between the age of

  • WBC > 100000/mm3

  • T – cell

  • < 1y/o

  • Lymphoblastic lymphoma with bone marrow lymphoblasts > 25%

  • t(9;22) or BCR-ABL fusion

  • t(4;11) or MLL-AF4 fusion

  • Other MLL gene rearrangement

  • Hypodiploidy ( chr 44 or less)

Poor prognosis i l.jpg
Poor Prognosis (I) between the age of

  • Acute lymphoblastic leukemia

Relapse l.jpg
Relapse between the age of

  • Bone marrow– the most common site,

    blast cell increase

  • CNS– IICP ( vomiting, headache,

    papilledema, lethargy)


    Behavior disturbance

  • Testis– painless swelling

Survival rates l.jpg
Survival rates between the age of

  • 75 % to 80% of children with ALL survive at least 5 years from diagnosis with current treatments that incorporate systemic therapy (e.g., combination chemotherapy) and specific central nervous system (CNS) preventive therapy (i.e., intrathecal chemotherapy with or without cranial irradiation).

Recurrent l.jpg
Recurrent between the age of

  • The most important extramedullary sites of relapse are the CNS and the testes.

Treatment l.jpg
Treatment between the age of

  • Chemotherapy– reach to remission(blast<5%)

  • CNS prophylaxis

    Intrathecal C/T

    Cranial irradiation

  • Bone marrow transplantation

Management and treatment l.jpg
Management and treatment between the age of

  • Hydration, prevention of hyperuricemia and tumor lysis syndrome.

  • Antibiotics, may need the 3rd generation of cephalosporin or other strong antibiotics, even antifungal agents.

Management and treatment33 l.jpg
Management and treatment between the age of

  • Chemotherapy(include remission induction, consolidation & maintenance.

  • CNS prophylaxis with chemotherapeutic agents(methotrexate 10~15mg, intrathecal injection).

Management and treatment34 l.jpg
Management and treatment between the age of

  • Blood transfusion(component therapy)

  • Nutritional support

  • Bone marrow transplantation

  • Growth factor

Treatment35 l.jpg
Treatment between the age of

  • The primary treatment for ALL is chemotherapy.

  • Radiation therapy may be used in certain cases

  • Bone marrow transplantation is being studied in clinical trials.

Treatment chemotherapy l.jpg
Treatment : Chemotherapy between the age of

  • uses drugs to kill cancer cells

  • drugs may be taken by mouth, or may be put into the body by a needle in a vein or muscle.

  • All chemotherapy is stopped after two to three years of treatment .

Treatment chemotherapy37 l.jpg
Treatment : Chemotherapy between the age of


  • Used in induction and reinduction therapy and also given as intermittent pulses during continuation therapy.

  • toxicity :

    fluid retention, increased appetite, transient diabetes, acne, striae, personality changes, peptic ulcer, immunosuppression, osteoporosis, growth retardation; caution in diabetes, fungal infections, and osteonecrosis

Slide38 l.jpg

Vincristine: between the age of

  • toxicity :

    Peripheral neuropathy manifested by constipation, ileus, ptosis, vocal cord paralysis, jaw pain, abdominal pain, loss of deep tendon reflexes; reduce dosage with severe peripheral neuropathy; bone marrow depression; local ulceration with extravasation, SIADH

Slide39 l.jpg

Asparaginase between the age of

  • local rash, hives, anaphylaxis; bone marrow depression, hyperglycemia, hepatotoxicity, and bleeding may occur.


  • Myelosuppression and thrombocytopenia; may cause cardiac arrhythmias immediately following administration and cardiomyopathy after long-term use; nausea, vomiting, stomatitis, and alopecia; extravasation may occur, resulting in severe tissue necrosis; caution with impaired hepatic, renal, or biliary function.

Slide40 l.jpg

Methotrexate (Folex PFS) between the age of

  • Hematologic, renal, GI, pulmonary, and neurologic systems; discontinue if significant drop in blood counts; aspirin, NSAIDs, or low-dose steroids may be administered concomitantly with MTX (possibility of increased toxicity with NSAIDs, including salicylates, has not been tested)

Radiation therapy l.jpg
Radiation Therapy between the age of

  • uses x-rays or other high-energy rays to kill cancer cells and shrink tumors.

Treatmet for vhr l.jpg
Treatmet for VHR between the age of

Induction:(10 weeks)

  • Prednisolone,Vincristine,Idarubicin,



    Consolidation:(8 weeks)

  • 6-MP,MTX,TIT

    Reinduction:(7 weeks)

  • Dexamethasone, ,Vincristine,Idarubicin,



Bone marrow transplantation l.jpg
Bone Marrow Transplantation between the age of

  • Hematopoietic stem cell transplantation is an option for very high-risk cases (e.g., Philadelphia chromosome-positive ALL) or those who develop an early relapse in the bone marrow.

Bone marrow transplantation44 l.jpg
Bone Marrow Transplantation between the age of

  • a newer type of treatment.

  • high doses of chemotherapy with or without radiation therapy are given to destroy all of the bone marrow in the body.

  • Healthy marrow is then taken from another person (a donor).

  • autologous bone marrow transplant, is being studied in clinical trials.

Treatment45 l.jpg
Treatment between the age of

Induction : 4 weeks

  • Hyhration.

  • Allopurinol

  • Vincristine iv qw & Prednisolone po qd

  • L- asparaginase

  • Mediastinum or spine tumor : R/T

Treatment46 l.jpg
Treatment between the age of

CNS prophylaxis

  • Intrathecal ingestion : methotrexate

  • Intrathecal ingestion : methotrexate ,Ara-C, hydrocortisone

  • High risk:Intrathecal ingestion C/T&R/T

Thanks l.jpg
THANKS ! between the age of